Investor Presentaiton

African Markets Rapid growth expected until 2020 at circa 10% CAGR Fuelled by increasing healthcare expenditure and NCDs > 50 pharmaceutical manufacturers - 20% local - 80% MNCs 4 major groups - MNCs, Chinese, Indian, Northern and Southern Africa Most imports from India, Switzerland, UK, SA and France Manufacturing relies on imports - 95% of raw materials imported Changing focus of MoH and Donors / NGOs Antibiotics, analgesics, and antihistamines dominate Poverty encourages prevalence of counterfeit drugs Self-medication raises prospects for OTCS Rising health insurance numbers underpin future growth IMPERIAL HEALTH SCIENCES TM

View entire presentation